Swiss Private Equity & Corporate Finance Association
Schweizerische Vereinigung für Unternehmensfinanzierung
Association Suisse des Investisseurs en Capital et de Financement
E | D | F

Login



Forgotten password

Visit us on XING!

Visit us on LinkedIn!

Therachon Raises $60 Million Mezzanine Financing to Advance Lead Program in Achondroplasia and to Ex

Therachon AG, a clinical-stage biotechnology company focused on rare diseases, today announced it has completed a $60 million mezzanine financing led by Novo Holdings and joined by new investors Cowen Healthcare Investments, Pfizer Ventures and funds managed by Tekla Capital Management LLC. Existing investors Versant Ventures, OrbiMed, Bpifrance and Inserm Transfert Initiative also participated. Blum & Grob Attorneys (Christian Koller and Ralph Imoberdorf) acted as Swiss counsel to Therachon.

 read more


Back to overview

Full Members
Contact

Swiss Private Equity & Corporate Finance Association
SECA
Grafenauweg 10
Postfach 4332
6304 Zug
Switzerland

Phone: +41 41 724 65 75